6 Reasons the Annual Flu Shot Matters More When You Have Diabetes or Asthma

Chronic inflammation is the baseline state in both diabetes and asthma. In type 2 diabetes, persistently high blood glucose blunts the function of neutrophils and macrophages, the white blood cells that reach an infection site first. In asthma, the airways are in a state of ongoing immune activation. When influenza arrives on top of either condition, the immune system is not starting from rest. A 2019 study published in Diabetes Care found that adults with type 2 diabetes had a 6-fold higher risk of influenza-related hospitalisation compared to adults without the condition. The flu shot reduces that hospitalisation risk by 30 to 40 percent in diabetic patients, according to the same body of research. That is not a marginal benefit.
Any infection raises cortisol and adrenaline levels. Both hormones tell the liver to release glucose into the bloodstream. For someone without diabetes, the pancreas compensates. For someone with type 1 or type 2 diabetes, that compensation either does not happen or is incomplete. A straightforward flu infection can push blood glucose into ranges that require emergency management, and in some cases, trigger diabetic ketoacidosis even in type 2 patients who have never experienced it before. Vaccination does not guarantee you will not get flu, but it significantly reduces severity. A milder infection means a smaller cortisol spike, which means a more manageable glucose response. The chain is direct.
Respiratory viruses are the leading cause of asthma exacerbations in adults and children. Influenza is among the most damaging of these because it infects the epithelial cells lining the airways, the same cells already compromised in asthmatic airways. The resulting inflammation narrows passages that are already prone to narrowing. A 2017 Cochrane review of influenza vaccination in people with asthma found that vaccination reduced the number of asthma exacerbations requiring oral corticosteroids. For patients already on inhaled corticosteroids, adding a flu-related exacerbation can mean stepping up to systemic steroids, which carry their own metabolic and immune costs. The shot is not a rescue inhaler, but it removes one of the most reliable triggers from the equation.
Flu weakens the respiratory epithelium, opening the door for secondary bacterial pneumonia, most commonly from Streptococcus pneumoniae or Staphylococcus aureus. In people with diabetes, that bacterial infection spreads faster because the high-glucose environment accelerates bacterial growth. In people with asthma, pneumonia compounds an already compromised respiratory system. India's pneumonia burden is significant: the country accounts for a disproportionate share of global pneumonia deaths, and diabetic patients are consistently overrepresented in severe pneumonia cases at tertiary hospitals. Flu vaccination reduces the risk of secondary bacterial pneumonia by approximately 27 percent, according to a meta-analysis in The Lancet Infectious Diseases. That number matters in a country where ICU beds are finite.

A common reason people with diabetes or asthma skip the flu shot is concern about interaction with their current medications, insulin, metformin, salbutamol, inhaled corticosteroids. There is no documented adverse interaction between the inactivated influenza vaccine and any of these drugs. The inactivated vaccine contains no live virus, so it cannot cause flu in immunocompromised patients. People with egg allergies, a historical contraindication, now have access to egg-free recombinant influenza vaccines. India's National Immunisation Technical Advisory Group (NITAG) recommends annual influenza vaccination for people with chronic conditions including diabetes and chronic respiratory disease. The recommendation exists precisely because the benefit-to-risk ratio in these populations is not close.
Influenza mutates rapidly. The strains circulating in one season are genetically different from those of the previous year, which is why immunity from last year's shot does not carry over. The World Health Organization monitors global flu surveillance data and updates vaccine composition twice a year, once for the northern hemisphere season, once for the southern. India's flu season peaks roughly between July and September, with a secondary peak around January to February, though regional variation exists. For someone with diabetes or asthma, missing a year's shot is not a neutral decision. It means entering a season with a condition that amplifies every complication, and no specific protection against the strains actually in circulation.